Abstract
Background: Estrogen receptor-α positive breast cancer is the most common dreadful disease and leading cause of death among women. In majority of human breast cancer, the interactions between kinases and ERα are considered to be critical in signaling pathway. Many kinases are known to regulate ERα activity. Recently Lemur tyrosine kinase-3 was identified as predictive oncogenic ERα regulator with a vital role in endocrine resistance. The role of LMTK3 in ERα regulation can be known by studying the interactions between them.
Objectives: To understand the transient interactions between ER-α and LMTK3 using computational technique.
Method: ERα -LMTK3 complex structure was obtained using PatchDock server. The interacting residues and interface area between ERα and LMTK3 were identified using PDBsum. Molecular dynamics simulation was used to study the conformational dynamics of ERα -LMTK3 complex.
Result: The approximate interface area of ERα-LMTK3 was found to be 3175 Å2 with atomic contact energy of 191.77 kcal/mol. PDBsum results revealed that some of the residues in C-terminal region of LMTK3 displayed non-bonding interactions with the residues in the phosphorylation sites (Ser104 and Ser106) of ERα. We noticed the total number of interface residues in ERα-LMTK3 complex to be 50 and the interface area for ERα as well as LMTK3 chain involved in interaction to be more than 2380 Å2. From conformational dynamics study, ERα-LMTK3 complex structure was found to be stable.
Conclusion: The outcomes of the current study enhance the understanding of interactions between ERα and LMTK3 which are thought to be critical in signaling pathway in majority of human breast cancers.
Keywords: Breast cancer, endocrine resistance, molecular dynamics simulation, PatchDock, PDBsum.
Graphical Abstract
Current Proteomics
Title:Unveiling the Transient Protein-Protein Interactions that Modulate the Activity of Estrogen Receptor(ER)-α by Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: An In Silico Study
Volume: 14 Issue: 2
Author(s): Venkata Satish Kumar Mattaparthi*Himakshi Sarma
Affiliation:
- Molecular Modelling and Simulation Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur-784 028, Assam,India
Keywords: Breast cancer, endocrine resistance, molecular dynamics simulation, PatchDock, PDBsum.
Abstract: Background: Estrogen receptor-α positive breast cancer is the most common dreadful disease and leading cause of death among women. In majority of human breast cancer, the interactions between kinases and ERα are considered to be critical in signaling pathway. Many kinases are known to regulate ERα activity. Recently Lemur tyrosine kinase-3 was identified as predictive oncogenic ERα regulator with a vital role in endocrine resistance. The role of LMTK3 in ERα regulation can be known by studying the interactions between them.
Objectives: To understand the transient interactions between ER-α and LMTK3 using computational technique.
Method: ERα -LMTK3 complex structure was obtained using PatchDock server. The interacting residues and interface area between ERα and LMTK3 were identified using PDBsum. Molecular dynamics simulation was used to study the conformational dynamics of ERα -LMTK3 complex.
Result: The approximate interface area of ERα-LMTK3 was found to be 3175 Å2 with atomic contact energy of 191.77 kcal/mol. PDBsum results revealed that some of the residues in C-terminal region of LMTK3 displayed non-bonding interactions with the residues in the phosphorylation sites (Ser104 and Ser106) of ERα. We noticed the total number of interface residues in ERα-LMTK3 complex to be 50 and the interface area for ERα as well as LMTK3 chain involved in interaction to be more than 2380 Å2. From conformational dynamics study, ERα-LMTK3 complex structure was found to be stable.
Conclusion: The outcomes of the current study enhance the understanding of interactions between ERα and LMTK3 which are thought to be critical in signaling pathway in majority of human breast cancers.
Export Options
About this article
Cite this article as:
Kumar Mattaparthi Satish Venkata *, Sarma Himakshi, Unveiling the Transient Protein-Protein Interactions that Modulate the Activity of Estrogen Receptor(ER)-α by Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: An In Silico Study, Current Proteomics 2017; 14 (2) . https://dx.doi.org/10.2174/1570164614666161206164330
DOI https://dx.doi.org/10.2174/1570164614666161206164330 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery Molecular Genetics and Epidemiology of Osteoporosis
Current Pharmacogenomics Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Synthesis of Chrysin, Quercetin and Naringin Nitroderivatives: Antiproliferative, Anti-inflammatory and Antioxidant Activity
Letters in Drug Design & Discovery Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Current Molecular Medicine P53 Mdm2 Inhibitors
Current Pharmaceutical Design Liver-Enriched Transcription Factors and Their Role in Regulating UDP Glucuronosyltransferase Gene Expression
Current Drug Metabolism Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Current Pharmaceutical Design Adrenergic Action in Breast Cancer
Current Cancer Therapy Reviews Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECT and PET
Current Medicinal Chemistry Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery Gender Specific Drug Metabolism of PF-02341066 in Rats — Role of Sulfoconjugation
Current Drug Metabolism Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Neuroprotective Effects of Nonsteroidal Anti-inflammatory Drugs on Neurodegenerative Diseases
Current Pharmaceutical Design Aryl- and Heteroaryl-Thiosemicarbazone Derivatives and Their Metal Complexes: A Pharmacological Template
Recent Patents on Anti-Cancer Drug Discovery Recent Results in Nonlinear Strain and Modulus Imaging
Current Medical Imaging Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Current Drug Targets Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery
Current Pharmaceutical Design Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
Current Radiopharmaceuticals Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration
Current Cancer Drug Targets